GS-4571
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS-4571, covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 1]